FILANA THERAPEUTICS, INC. (FLNA) Insider Trading Disclosures
FILANA THERAPEUTICS, INC. (FLNA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: FLNA
CIK: 1069530
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerAnna Horndahl
Audit LocationAustin, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-01 | 2026-09-29 | FORM 4 | 0001437749-26-031654 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-28 | FORM 4 | 0001437749-26-031597 | View SEC Doc Filr Page |
| 8-K | 2026-09-22 | 2026-09-22 | FORM 8-K | 0001171843-26-006161 | View SEC Doc Filr Page |
| 8-K | 2026-09-18 | 2026-09-17 | FORM 8-K | 0001437749-26-030751 | View SEC Doc Filr Page |
| 10-Q | 2026-07-29 | 2026-06-30 | FORM 10-Q | 0001437749-26-024752 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-29 | FORM 8-K | 0001171843-26-004982 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-11 | FORM 8-K | 0001437749-26-020562 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | FORM 10-Q | 0001437749-26-015664 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | FORM 8-K | 0001171843-26-003119 | View SEC Doc Filr Page |
| ARS | 2026-04-28 | 2025-12-31 | FORM ARS | 0001437749-26-013656 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-28 | 2026-06-11 | FORM DEF 14A | 0001437749-26-013654 | View SEC Doc Filr Page |
| 8-K | 2026-04-28 | 2026-04-22 | FORM 8-K | 0001437749-26-013638 | View SEC Doc Filr Page |
| 10-K | 2026-03-12 | 2025-12-31 | FORM 10-K | 0001437749-26-007962 | View SEC Doc Filr Page |
| 8-K | 2026-03-12 | 2026-03-12 | FORM 8-K | 0001171843-26-001506 | View SEC Doc Filr Page |
| 8-K | 2026-03-10 | 2026-03-10 | FORM 8-K | 0001437749-26-007422 | View SEC Doc Filr Page |
| 8-K | 2026-02-19 | 2026-02-19 | FORM 8-K | 0001171843-26-000922 | View SEC Doc Filr Page |
| 8-K | 2025-12-23 | 2025-12-19 | FORM 8-K | 0001437749-25-038605 | View SEC Doc Filr Page |
| 8-K/A | 2025-12-22 | 2025-10-21 | FORM 8-K/A | 0001437749-25-038544 | View SEC Doc Filr Page |
| 8-K | 2025-12-18 | 2025-12-15 | FORM 8-K | 0001437749-25-038313 | View SEC Doc Filr Page |
| 8-K | 2025-12-17 | 2025-12-12 | FORM 8-K | 0001437749-25-038157 | View SEC Doc Filr Page |
| EFFECT | 2025-12-05 | — | EFFECT Filing | 9999999995-25-003554 | View SEC Doc Filr Page |
| 424B2 | 2025-12-05 | — | 424B2 | 0001493152-25-026408 | View SEC Doc Filr Page |
| CORRESP | 2025-12-03 | — | CORRESP Filing | 0001493152-25-025914 | View SEC Doc Filr Page |
| 8-K | 2025-12-03 | 2025-11-26 | FORM 8-K | 0001437749-25-036710 | View SEC Doc Filr Page |
| 4 | 2025-11-25 | 2025-11-24 | FORM 4 | 0001437749-25-036321 | View SEC Doc Filr Page |